1Zha S,Yegnasubramanian V,Nelson W G,et al.Cyclooxy-genases in cancer:progress and perspective[J].Cancer Lett,2004,215(1):1-20.
2Hawk E,Viner J L.The adenoma prevention with celecoxiband prevention of colorectal sporadic adenomatous polyps tri-als:stepping stones to progress[J].Cancer Epidemiol Bio-markers Prev,2007,16(2):185-187.
3Kim Y Y,Lee E J,Kim Y K,et al.Anti-cancer effects ofcelecoxib in head and neck carcinoma[J].Mol Cells,2010,29(2):185-194.
4Sobolewski C,Cerella C,Dicato M,et al.The role of cy-clooxygenase-2 in cell proliferation and cell death in humanmalignancies[J].Int J Cell Biol,2010,2010:215158.
5Nie D.Cyclooxygenases and lipoxygenases in prostate andbreast cancers[J].Front Biosci,2007,12:1574-1585.
7Ladetto M,Vallet S,Trojan A,et al.Cyclooxygenase-2(COX-2)is frequently expressed in multiple myeloma and isan independent predictor of poor outcome[J].Blood,2005,105(12):4784-4791.
8Singh B,Cook K R,Vincent L,et al.Role of COX-2 in tu-morospheres derived from a breast cancer cell line[J].J SurgRes,2011,168(1):39-49.
9Schmitz K J,Wohlschlaeger J,Lang H,et al.Cyclooxygen-ase-2 overexpression is a feature of early and well-differentia-ted hepatocellular carcinoma with a favourable prognosis[J].J Clin Pathol,2009,62(8):690-693.
10Oshima M,Dinchuk J E,Kargman S L,et al.Suppressionof intestinal polyposis in Apc delta716 knockout mice by in-hibition of cyclooxygenase 2(COX-2)[J].Cell,1996,87(5):803-809.
4Subbaramaiah K, Dannenberg AJ. Cyclooxygenase-2: a molecula target for cancer prevention and treatment. Trends Pharmacol Sci, 2003, 24: 96-102.
5Chhanabhai M, Krajewski S, Krajewska M, et al. Immunohistochemical analysis of interleukin- 1β -converting enzyme/Ced-3 family protease, CPP32/caspase23, in Hodgkin's disease. Blood, 1997, 90: 2451-2455.
6Jaffe ES, Harris NL, Stein H, et al, World Health Organization classification of tumours pathology and genetics of haemotopoietic and lymphoid tissue. Lyon: IARC Press, 2001.
7Singh B, Lucci A. Role of cyclooxygenase-2 in breast cancer. J Surg Res, 2002, 108: 173-179.
8Souza RF, Shewmake K, Beer DG, et al. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenecarcinoma cells. Cancer Res, 2000, 60: 5767-5772.
9Richter M, Weiss M, Weinberger I, et al. Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors. Carcinogenesis, 2001, 22: 17-25.
10Rosenberg L, Louik C, Shapiro S. Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma. Cancer, 1998, 82: 2326-2333.
6Hong L,Li S,Liu L,et al. The value of MG7-Ag and COX-2 for predic- ting malignancy in gastric precancerous lesions. Cell biology internation- al,2010,34:873-876.
7Serra KP, Sarian LO, Rodrigues-Peres RM, et al. Expression of cyelooxy- genase-2 (COX-2) and p53 in neighboring invasive and in situ compo- nents of breast tumors. Acta Histochemica,2012,114:226-231.
8Romano M, Ricci V, Memoli A, el al. Helicobacter pylori up-regulates cy- clooxygenase-2 mRNA expression and Prostaglandin E2 synthesis in MKN28 gastric mucosal cells in vitro. J Biol Chem, 1998,273 : 28560- 28563.
9Akhtar M, Cheng Y, Magno RM, et al. Promotermethylation regulalion He- lieobacter pylori-stimulated cyclooxygenase-2 expression in gastric epithe- lial cells. Cancer Res ,2001,61:2399-2403.
10Liu F, Pan KF, Zhang XM, et al. Genetic variants in COX-2 : Expression and risk of gastirie cancer and its precursors in a Chinese population. Gastrenterology, 2006,130 : 1975 -1984.
